New Castle University, Newcastle-upon-Tyne, UK
Prof. Nick Embleton
Consultant Neonatal Pediatrician and Professor of Neonatal Medicine
Professor Nick Embleton is Consultant Neonatal Pediatrician and Professor of Neonatal Medicine, New Castle University, Newcastle-upon-Tyne, UK. He qualified with honors in Medicine from Newcastle University in 1990 (Bachelor of Medicine, Bachelor of Surgery). His doctoral thesis (MD 2002) was on protein requirements in preterm infants.
Professor Embleton now leads a broad portfolio of translational research (www.neonatalresearch.net). He is involved in studies that include large-scale National Institute for Health Research collaborative trials (>5,000 infants recruited), which explore the role of early feeding in preterm infants and the impact of supplemental lactoferrin (ELFIN and SIFT studies). Embedded within these large pragmatic trials are mechanistic microbiomic and metabolomic studies (MAGPIE: http://www.isrctn.com/ISRCTN12554594), which collected .25,000 samples of urine and stools from ~500 infants in 12 different UK hospitals. He also coordinates the Newcastle Preterm Birth Growth Study tracking the growth, cognitive, and metabolic outcomes of children who were born preterm into late adolescence.
Currently, Professor Embleton is Chief Investigator on two randomized controlled trials: 1) INDIGO, exploring the impact of an exclusive human milk diet in very preterm infants and 2) FLAMINGO, Feeding in late and Moderately Preterm Infants Nutrition and Growth Outcomes. He is a member of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition Committee of Nutrition, and is Chair of the UK-based multidisciplinary Neonatal Nutrition Network (N3), as well as working with colleagues in Liverpool, UK, and Ibdadan, Nigeria, helping to establish a Neonatal Nutrition Network in sub-Saharan Africa. Professor Embleton is also clinical lead for qualitative studies exploring reproductive and/or neonatal loss (the Butterfly project www.neonatalbutterflyproject.org). He has published more than 200-peer reviewed articles, has more than >6,000 citations, and his H-index is 38.